Cargando…
Re: Molecular testing to deliver personalised chemotherapy recommendations
BACKGROUND: There is an increasing focus over time on the discovery and validation of biomarkers in cancer medicine, which can inform the identification of patients that are most likely to benefit from treatment, which therapy is most likely to be effective, and treatments that may not be safe. BODY...
Autores principales: | Gibbs, Peter, Hong, Wei, Tie, Jeanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483773/ https://www.ncbi.nlm.nih.gov/pubmed/37674128 http://dx.doi.org/10.1186/s12916-023-03036-w |
Ejemplares similares
-
Can learning health systems help organisations deliver personalised care?
por: Nwaru, Bright I., et al.
Publicado: (2017) -
Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment
por: Olivier, Timothée, et al.
Publicado: (2022) -
‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing
por: Ramdas, Kamalini, et al.
Publicado: (2020) -
From disease modelling to personalised therapy in patients with
CEP290 mutations
por: Molinari, Elisa, et al.
Publicado: (2017) -
Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia
por: Garfield, Benjamin, et al.
Publicado: (2021)